Alvotech Files Form 6-K with SEC

Ticker: ALVOW · Form: 6-K · Filed: Apr 19, 2024 · CIK: 1898416

Alvotech 6-K Filing Summary
FieldDetail
CompanyAlvotech (ALVOW)
Form Type6-K
Filed DateApr 19, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-k, reporting

TL;DR

Alvotech filed a 6-K, confirming its foreign private issuer status and 20-F filing. Standard reporting.

AI Summary

Alvotech, a biopharmaceutical company, filed a Form 6-K on April 19, 2024. The filing is a report of a foreign private issuer and indicates that Alvotech files annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.

Why It Matters

This filing confirms Alvotech's status as a foreign private issuer and its reporting obligations with the SEC, providing transparency for investors.

Risk Assessment

Risk Level: low — This filing is a routine administrative report and does not contain new material financial or operational information that would typically increase risk.

Key Players & Entities

  • Alvotech (company) — Registrant
  • 001-41421 (company) — SEC File Number
  • 9, Rue de Bitbourg, L-1273 Luxembourg (company) — Principal executive office address
  • Alvotech Lux Holdings S.A.S. (company) — Former company name

FAQ

What type of filing is this Form 6-K?

This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.

What is Alvotech's SEC file number?

Alvotech's SEC file number is 001-41421.

Does Alvotech file annual reports under Form 20-F or 40-F?

Alvotech indicates it files annual reports under cover of Form 20-F.

Where is Alvotech's principal executive office located?

Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.

What was Alvotech's former company name?

Alvotech's former company name was Alvotech Lux Holdings S.A.S.

Filing Stats: 338 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-04-19 08:05:34

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: April 19, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.